Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer's disease

References

• Navarro A, Boveris A. Rat brain and liver mitochondria develop oxidative stress and loss enzymatic activities on aging. Ann J Physiol Regul Integr Comp Physiol 2004;287:R1244–9. doi: 10.1152/ajpregu.00226.2004
   PubMed Web of Science ®Google Scholar
• Bratic A, Larsson N-G. The role of mitochondria in aging. J Clin Invest 2013;123:951–7. doi: 10.1172/JCI64125
   PubMed Web of Science ®Google Scholar
• Stocco DM, Cascarano J, Wilson MA. Quantitation of mitochondrial DNA, RNA, and protein in starved and starved-refed rat liver. J Cell Physiol 1977;90:295–306. doi: 10.1002/jcp.1040900215
   PubMed Web of Science ®Google Scholar
• Maure I, Zierz S, Moller H-J. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 2000;21:455–62. doi: 10.1016/S0197-4580(00)00112-3
   PubMed Web of Science ®Google Scholar
• Heinemann I, Jahn M, Jahn D. The biochemistry of heme biosynthesis. Arch Biochem Biophys 2008;474:238–51. doi: 10.1016/j.abb.2008.02.015
   PubMed Web of Science ®Google Scholar
• Fukuda H, Casas A, Batle A. Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy. Int J Biochem Cell Biol 2005;37:272–6. doi: 10.1016/j.biocel.2004.04.018
   PubMed Web of Science ®Google Scholar
• Onyango IG, Dennis J, Khan SM. Mitochondrial dysfunction in Alzheimer's disease and the rationale for bioenergetics based therapies. Aging Dis 2016;7:201–14. doi: 10.14336/AD.2015.1007
   PubMed Web of Science ®Google Scholar
• Johri A, Beal MF. Mitochondrial dysfunction in neurodegenerative diseases. J Pharm Exp Ther 2012;342:619–30. doi: 10.1124/jpet.112.192138
   PubMed Web of Science ®Google Scholar
• Kalra J, Kumar P, Majeed ABA, Prakash A. Modulation of LOX and COX pathways via inhibition of amyloidogenesis contributes to mitoprotection against β-amyloid oligomer-induced toxity in an animal model of Alzheimer's disease in rats. Pharma Biochem Behav 2016;146–147:1–12. doi: 10.1016/j.pbb.2016.04.002
   PubMed Web of Science ®Google Scholar
• Wang L, Guo L, Sun H, Shao M, Beck SJ, Li L, et al. Synaptosomal mitochondrial dysfunction in 5xFAD mouse model of Alzheimer's disease. PLoS One 2016;11:e0150441. doi: 10.1371/journal.pone.0150441
   PubMed Web of Science ®Google Scholar
• Ogura S, Maruyama K, Hagiya Y, Sugiyama Y, Tsuchiya K, Takahashi K, et al. The effect of 5-aminolevulinic acid on cytochrome c oxidase activity in mouse liver. BMC Res Notes 2011;4:66. doi: 10.1186/1756-0500-4-66
   PubMedGoogle Scholar
• Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer's disease plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 2003;39:409–21. doi: 10.1016/S0896-6273(03)00434-3
   PubMed Web of Science ®Google Scholar
• Oishi M, Nairn AC, Czernik AJ, Lim GS, Isohara T, Gandy SE, et al. The cytoplasmic domain of Alzheimer's amyloid precursor protein is phosphorylated at Thr654, Ser655, and Thr668 in adult rat brain and cultured cells. Mol Med 1997;3:111–23.
   PubMed Web of Science ®Google Scholar
• Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, et al. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci 2007;27:3639–49. doi: 10.1523/JNEUROSCI.4396-06.2007
   PubMed Web of Science ®Google Scholar
• Morohashi Y, Kan T, Tominari Y, Okamura Y, Watanabe N, Sato C, et al. C-terminal fragment of presenilin is the molecular target of a dipeptidic γ-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester). J Biol Chem 2006;281:14670–6. doi: 10.1074/jbc.M513012200
   PubMed Web of Science ®Google Scholar
• Kondo M, Shiono M, Itoh G, Takei N, Matsushima T, Maeda M, et al. Increased amyloidogenic processing of transgenic human APP in X11-like deficient mouse brain. Mol Neurodegener 2010;5:35. doi: 10.1186/1750-1326-5-35
   PubMed Web of Science ®Google Scholar
• Billings LM, Oddo S, Green KN, McGaugh JL, LaFeria FM. Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005;45:675–88. doi: 10.1016/j.neuron.2005.01.040
   PubMed Web of Science ®Google Scholar
• Lesne SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA, et al. Brain amyloid-β oligomers in aging and Alzheimer's disease. Brain 2013;136:1383–98. doi: 10.1093/brain/awt062
   PubMed Web of Science ®Google Scholar
• Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem 2008;283:29615–9. doi: 10.1074/jbc.R800019200
   PubMed Web of Science ®Google Scholar
• Cole SL, Vassar R. The role of amyloid precursor protein processing by BACE1, the β-secretase, in Alzheimer disease pathophysiology. J Biol Chem 2008;283:29621–5. doi: 10.1074/jbc.R800015200
   PubMed Web of Science ®Google Scholar
• Steinwr H, Fluhrer R, Haass C. Intramembrane proteolysis by g-secretase. J Biol Chem 2008;283:29627–31. doi: 10.1074/jbc.R800010200
   PubMed Web of Science ®Google Scholar
• Suzuki T, Nakaya T. Regulation of amyloid β-protein precursor by phosphorylation and protein interactions. J Biol Chem 2008;283:29633–7. doi: 10.1074/jbc.R800003200
   PubMed Web of Science ®Google Scholar
• Darten DM, Cadelina GW, Hoque N, DeCarr LB, Guss VL, Yang L, et al. Tau transgenic mice as models for cerebrospinal fluid tau biomarkers. J Alzheimers Dis 2011;24:1–15.
   Web of Science ®Google Scholar
• Oh K-J, Perez SE, Lagalwar S, Vana L, Binder L, Mufson EJ. Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis. Int J Alzheimer Dis 2010;ID780102.
   Google Scholar
• Kwong LK, Sohal RS. Age-related changes in activities of mitochondrial electron transport complexes in various tissues of the mouse. Arch Biochem Biophys 2001;373:16–22. doi: 10.1006/abbi.1999.1495
   Web of Science ®Google Scholar
• Cardoso SM, Proenca MT, Santos S, Santana I, Oliveria CR. Cytochrome c oxidase is decreased in Alzheimer's disease platelets. Neurobiol Aging 2004;25:105–10. doi: 10.1016/S0197-4580(03)00033-2
   PubMed Web of Science ®Google Scholar
• Kish SJ, Mastrogiacomo F, Guttman M, Furukawa Y, Taanman JW, Dozic S, et al. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in herediary soinocerebellar ataxia disorders: a nonspecific change? J Neurochem 1993;72:700–7. doi: 10.1046/j.1471-4159.1999.0720700.x
   Web of Science ®Google Scholar
• Atamna H, Liu J, Ames BN. Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts. J Biol Chem 2001;276:48410–6. doi: 10.1074/jbc.M108362200
   PubMed Web of Science ®Google Scholar
• Benilova I, Karran E, De Strooper B. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 2012;15:349–57. doi: 10.1038/nn.3028
   PubMed Web of Science ®Google Scholar
• Gandy S, DeKosky ST. Toward the treatment and prevention of Alzhemer's disease: rational strategies and recent progress. Ann Rev Med 2013;64:367–83. doi: 10.1146/annurev-med-092611-084441
   PubMed Web of Science ®Google Scholar
• Suzuki T, Araki Y, Yamamoto T, Nakaya T. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis. J Biochem 2006;139:949–55. doi: 10.1093/jb/mvj121
   PubMed Web of Science ®Google Scholar
• Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005;307:1282–8. doi: 10.1126/science.1105681
   PubMed Web of Science ®Google Scholar
• Araki Y, Kawano T, Taru H, Saito Y, Wada S, Miyamoto K, et al. The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport. EMBO J 2007;26:1475–86. doi: 10.1038/sj.emboj.7601609
   PubMed Web of Science ®Google Scholar
• Morel M, Heraud C, Nicaise C, Suain V, Brion JP. Level of kinesin light cgain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer's disease: implications for axoplasmic transport. Acta Neuropathol 2012;123:71–84. doi: 10.1007/s00401-011-0901-4
   PubMed Web of Science ®Google Scholar
• Chiba K, Araseki M, Nozawa K, Furukori K, Araki Y, Matsushima T, et al. Quantitative analysis of APP axonal transport in neuron: role of JIP1 in enhanced APP anterograde transport. Mol Biol Cell 2014;25:3569–80. doi: 10.1091/mbc.E14-06-1111
   PubMed Web of Science ®Google Scholar
• Hirokawa N, Noda Y, Tanaka Y, Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol 2009;10:682–96. doi: 10.1038/nrm2774
   PubMed Web of Science ®Google Scholar